Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Clinical trial NCT06965374 · RECRUITING

Trial details

NCT number: NCT06965374
Sponsor: AbbVie
Status: RECRUITING
Study type: OBSERVATIONAL

Parkinson Disease

Start date: 2025-06-04
Primary completion: 2027-06-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.